10x Genomics, Inc. — Director's Dealing 2019

Sep 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2019-09-11

Reporting Person: ROBERTS BRYAN E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-11	Stock Option (right to buy)	$39.00	A	40000	Acquired	2029-09-11	Class A Common Stock (40000)	Direct

Footnotes

F1: This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one thirty-sixth of the shares on October 11, 2019 and each month thereafter, subject to the reporting person continuing as a service provider through each such date.

F2: The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company, which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares, and the reporting person may be deemed the indirect beneficial owner of the reported shares through his interest in the Management Company. The reporting person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.